Metraipolis › archive › dc_975a019ef00d

Real-World Survival Over 25 Years in Extensive-Stage Small-Cell Lung Cancer: The Impact of Immune Checkpoint Inhibitors — Europe PMC PMID:42227304

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42227304
DOI
10.1111/1759-7714.70316
License (as archived)
solo-consultazione
Archived
2026-10-31T23:51:11.354Z
SHA-256 of the archived text
1832d3750f1f5594bfbbe89d5d9f5c4012afa8ec84af40984d4c7ff5a7aebbf4
Stable URL of this page
https://metraipolis.com/documento/dc_975a019ef00d

How to cite

Real-World Survival Over 25 Years in Extensive-Stage Small-Cell Lung Cancer: The Impact of Immune Checkpoint Inhibitors — Europe PMC PMID:42227304 — Europe PMC (en), https://europepmc.org/article/MED/42227304 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_975a019ef00d (Metraipolis archive dc_975a019ef00d, sha256 1832d3750f1f5594bfbbe89d5d9f5c4012afa8ec84af40984d4c7ff5a7aebbf4)
BibTeX
@misc{dc975a019ef00d,
  title = {Real-World Survival Over 25 Years in Extensive-Stage Small-Cell Lung Cancer: The Impact of Immune Checkpoint Inhibitors — Europe PMC PMID:42227304},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42227304},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_975a019ef00d; sha256 1832d3750f1f5594bfbbe89d5d9f5c4012afa8ec84af40984d4c7ff5a7aebbf4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42227304. Agents can read the archived copy with the MCP tool read_document.